How to order a lumbar puncture for an adult patient with suspected Guillain-Barré Syndrome (GBS) and significant medical history, including hypertension and diabetes?

Lumbar Puncture Ordering for Suspected Guillain-Barré Syndrome

Order a lumbar puncture for CSF analysis including cell count with differential, protein, glucose, and cytology, but only after ensuring no contraindications exist and obtaining neurology consultation. 1

Pre-Procedure Assessment

Mandatory Contraindication Screening

Before ordering the LP, verify the patient does NOT have: 1

• Signs of increased intracranial pressure (papilledema, focal neurological deficits suggesting mass effect, altered consciousness) 1
• Coagulopathy or platelet count <50-100 × 10⁹/L (seek hematology consultation if platelets 50-100 × 10⁹/L) 1
• Local skin infection at puncture site 1
• Clinical instability (severe respiratory compromise requiring immediate intubation) 1
• Suspected spinal cord compression 1

When to Image Before LP

Obtain CT or MRI brain before LP if: 1

• Glasgow Coma Score <12 (some recommend <9) 1
• Focal neurological signs suggesting mass lesion 1
• New-onset seizures 1
• Severe immunocompromise (e.g., advanced HIV) 1
• Papilledema on examination 1

However, do NOT delay LP unnecessarily - in patients without these contraindications, proceed directly to LP rather than waiting for imaging, as delays can postpone critical diagnosis and treatment. 1

Specific CSF Studies to Order

Essential CSF Analysis 1

Order the following CSF studies:

• Cell count with differential - expect normal cell count or mild pleocytosis (10-50 cells/μL compatible with GBS, but >50 cells/μL suggests alternative diagnosis like infectious polyradiculitis) 1
• Protein level - classic finding is elevated protein with normal cell count (albuminocytological dissociation), though protein is normal in 30-50% of patients in the first week 1, 2
• Glucose with simultaneous serum glucose - should be normal in GBS; low CSF:plasma glucose ratio suggests bacterial or tuberculous meningitis 1
• Cytology for malignant cells - mandatory in cancer patients to exclude leptomeningeal metastases 1
• Gram stain and bacterial/viral cultures - to exclude infectious causes 1

Additional Studies in Specific Contexts 1

For patients on immune checkpoint inhibitors or with cancer history:

• CSF opening pressure 1
• PCR for HSV and other viruses if concurrent encephalitis suspected 1
• Flow cytometry in hematologic malignancy patients 1

Critical Timing Considerations

Perform LP during initial evaluation, ideally within 6-24 hours of presentation. 1 Do not wait for antibody test results before proceeding with LP and treatment, as normal CSF findings do not rule out GBS, especially in the first week. 1, 2

If the first LP shows normal protein and you have high clinical suspicion, consider repeat LP in 24-48 hours, as protein elevation may develop later in the disease course. 1

Concurrent Diagnostic Workup

Order these studies alongside or immediately after LP: 1

• MRI spine with and without contrast - to rule out compressive lesions and evaluate for nerve root enhancement/thickening 1
• Electrodiagnostic studies (EMG/NCS) - to evaluate polyneuropathy pattern and support diagnosis 1
• Serum antiganglioside antibodies - including anti-GQ1b for Miller Fisher variant, though negative results do not exclude GBS 1
• Pulmonary function testing (vital capacity, negative inspiratory force) - critical for monitoring respiratory status 1

Special Considerations for Comorbidities

For patients with hypertension and diabetes: 1

• Ensure blood pressure is controlled before LP to minimize bleeding risk 1
• Check HbA1c and glucose as part of reversible neuropathy workup 1
• Monitor for autonomic dysfunction more closely, as diabetes increases this risk 1

Common Pitfalls to Avoid

Do not assume normal CSF rules out GBS - up to 50% have normal protein in week one, and 10-30% in week two. 1 The diagnosis remains clinical, supported by ancillary testing.

Do not delay treatment waiting for LP results - if clinical suspicion is high and patient is deteriorating (grade 3-4 weakness, respiratory involvement), initiate IVIG or plasmapheresis immediately after obtaining CSF, not before starting therapy. 1

Avoid LP in patients on warfarin - switch to heparin and stop before procedure. 1